[HTML][HTML] Sarcopenia, obesity, and inflammation—results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study

M Cesari, SB Kritchevsky, RN Baumgartner… - The American journal of …, 2005 - Elsevier
Background: Age-related body-composition changes are associated with health-related
outcomes in elders. This relation may be explained by inflammation and hemostatic …

Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999–2004 National Health and Nutrition Examination Survey

JA Batsis, TA Mackenzie, JD Jones, F Lopez-Jimenez… - Clinical Nutrition, 2016 - Elsevier
Summary Background The Foundation for the National Institutes of Health Sarcopenia
Project validated cutpoints for appendicular lean mass (ALM) to identify individuals at risk for …

Sarcopenic obesity and inflammation in the InCHIANTI study

MA Schrager, EJ Metter, E Simonsick… - Journal of applied …, 2007 - journals.physiology.org
The aging process is often paralleled by decreases in muscle and increases in fat mass. At
the extreme these two processes lead to a condition known as “sarcopenic …

Association of lifestyle factors and inflammation with sarcopenic obesity: data from the PREDIMED‐Plus trial

I Abete, J Konieczna, MA Zulet… - Journal of Cachexia …, 2019 - Wiley Online Library
Background Sarcopenia is a progressive age‐related skeletal muscle disorder associated
with increased likelihood of adverse outcomes. Muscle wasting is often accompanied by an …

Sarcopenic obesity as a determinant of cardiovascular disease risk in older people: a systematic review

K Evans, D Abdelhafiz, AH Abdelhafiz - Postgraduate medicine, 2021 - Taylor & Francis
Background Aging is associated with body composition changes that include a reduction of
muscle mass or sarcopenia and an increase in visceral obesity. Thus, aging involves a …

Association between sarcopenia level and metabolic syndrome

SH Kim, JB Jeong, J Kang, DW Ahn, JW Kim, BG Kim… - PloS one, 2021 - journals.plos.org
Aims Metabolic syndrome (MetS) increases the risk of diabetes mellitus (DM),
cardiovascular disease (CVD), cancer, and mortality. Sarcopenia has been reported as a …

Inflammation: roles in aging and sarcopenia

GL Jensen - Journal of parenteral and enteral nutrition, 2008 - Wiley Online Library
Aging is associated with inflammatory chronic conditions such as obesity, cardiovascular
disease, insulin resistance, and arthritis. Sarcopenia—muscle loss with aging—is …

Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women

M Aubertin‐Leheudre, C Lord, EDB Goulet, A Khalil… - …, 2006 - Wiley Online Library
Objective: To compare sarcopenic‐obese and obese postmenopausal women for risk
factors predisposing to cardiovascular disease (CVD) and determine whether there may be …

[HTML][HTML] Associations between sarcopenia and metabolic risk factors: a systematic review and meta-analysis

Y Du, C Oh, J No - Journal of obesity & metabolic syndrome, 2018 - ncbi.nlm.nih.gov
Background Metabolic risk factors can impact sarcopenia, but the direct relationship of
metabolic risk factors with sarcopenia has not been examined. Our purpose was to …

Associations between inflammatory markers, body composition, and physical function: the Copenhagen Sarcopenia Study

RS Kamper, J Alcazar, LL Andersen… - Journal of Cachexia …, 2021 - Wiley Online Library
Background Chronic low‐grade inflammation has been suggested as one of the key
elements in the development of sarcopenia, but in contrast to disease‐related loss of muscle …